Compare Medpace Holdings Inc (MEDP) vs Banco Santander SA (SAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Banco Santander SA — how do they compare? Medpace Holdings Inc trades at $530.22 (market cap $15.08B), while Banco Santander SA trades at $13.66 (market cap $191.46B). The key difference: Banco Santander SA is far larger — about 12.7× Medpace Holdings Inc's market cap, and Banco Santander SA pays a 2.09% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | SAN | |
|---|---|---|
Market Cap | $15.08B | $191.46B |
Sector | Technology | Financials |
52-Week High | $620.59 | $14.37 |
52-Week Low | $308.88 | $8.40 |
Enterprise Value | $14.55B | — |
Dividend Yield | — | 2.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Banco Santander SA
Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →
